Born in 1987 and educated in Pharmaceutical Biotechnology. Gianluca worked in University of Perugia and Karolinska Institutet to investigate the effect of human mesenchymal stromal cells on fungal infections, their immunomodulatory effects and their toxicological and safety profile in animal models. In 2017 he joined the newborn Cellavos AB, to develop an MSCs based cell therapy for the equine field.
“A considerable amount of research has been done on cell therapies, now it’s time to bring them to the patients in the safest and more affordable way. That’s what I’m working on.”
Head of Production Development